Search

While Cabot Top Ten Report is often seen as being for more aggressive investors, some of its picks have turned out to be great longer-term investments. The key is finding stocks that have appeared multiple times in the Report, often as Editor’s Choice.

Most positions are up 5%-6% for the week, with a couple of exceptions.

Small caps continue to trend sideways as they have since the beginning of 2017. In the S&P 600 Small Cap Index, this means trading mostly in the 820 to 860 range with a few spikes above and a few below. There’s no doubt the market rally has lost momentum as the small cap index has traded mostly below its intermediate trend line over the last five weeks.

Mike Cintolo, our market timing expert, wrote earlier this week that he wouldn’t be surprised to see this correction develop one more leg down, and it looks like that’s what we’re getting. All the major indexes opened significantly lower yesterday, and while they rebounded partially in the afternoon, the turbulence sent the VIX surging to its highest level since the U.S. election.

The market is certainly healthier, but it probably won’t go straight up from here. In fact, it’s more likely that sellers will see this bounce as an opportunity, and we’ll get another, probably smaller, leg down before the market starts a sustainable new uptrend.

The action of the last couple of days has been a smack in the face for all investors, U.S. and emerging markets alike. As always, the Cabot growth disciplines tell us not to panic, but also not just to sit there and let the market take away your money. While we don’t have any changes to the portfolio tonight, this issue of Cabot Emerging Markets Investor shows a distinctly defensive tone, with a very heavy cash position and just two stocks rated Buy. We also have a new stock this week that’s perfectly suited to conditions. It’s a commodity play with a generous dividend, attractive valuation and a simple story. Read on for all the details.

CBD is hot, and acquisitions in the cannabis industry seem to occur daily, but the biggest marijuana stocks are cooling, at least for a while.

Long-term, however, I remain very bullish on both the companies and the stocks in the industry and am truly enjoying staying on top of the developments.

The gains so far this year, in both the sector and the portfolio, remain spectacular, but they won’t continue; I guarantee that corrections and volatility will come. And I also guarantee I’ll give you my best ideas on how to deal with them.

Our Cabot Cannabis Investor portfolio is up 35% this year. That’s more than 10 times the 3% gain for the S&P 500.

The broader cannabis sector has done well too, but not quite as well as our Cabot Cannabis Investor portfolio of the 12 best names in the space.

The New Cannabis Ventures Global Cannabis Stock Index and the ETFMG Alternative Harvest exchange traded fund (MJ) are up 14.5%. We’re up more than twice as much.

Our Cannabis Plus Insider Portfolio is up 39.3% since I launched it on March 29 last year. Here we have outperformed the market by threefold. The 39.3% advance compares to gains of 12.7% for the Russell 2000 index, and 22.3% for the S&P 500 over the same time. The smid-cap Russell 2000 is a more appropriate comp than large-cap names in the S&P 500. This portfolio invests in cannabis related companies that have the right kind of insider buying, and do not touch the plant.

This feels like one of those markets that you’re not sure you should trust given how volatile it was in February. But the combination of revenue growth, earnings growth and decent charts, especially among growth stocks, suggests it’s best not to try to predict too far into the future. For now, the evidence in front of us favors the bulls.

The 5G technology revolution is almost here. And that means it’s time to add these three wireless stocks to your portfolio.

As we cruise toward the holiday season, it’s been another good week for the market—as of this morning, the S&P 500 is up nearly 2% while the Nasdaq, S&P 400 Midcap and S&P 600 SmallCap (now up seven weeks in a row!) all are up in the 2.5% to 3% range.

Unsure of where to find profitable stocks in this highly volatile market? Here’s how to find COVID-19 stock market winners.

Day trading is like gambling, which is why we don’t advise it. But that didn’t stop neophyte investor Dave Portnoy from doing it in the midst of a pandemic.

Do you prefer growth stocks, value stocks or income stocks? If you don’t know, now is the time to decide, before the market rebounds from the election.

Investing isn’t all about buying when the market is hot. For the following three reasons, bad markets have their benefits too. (I’m a growth investor, which is a decision I only came to after I started working at Cabot, so these reasons apply to growth investing.)

The options market is vastly different now than it once was, thanks to computers. You can’t compete with algorithms, so what do you do?

Ahead of the long holiday weekend the market had yet another good week. The S&P 500 gained 1.75%, the Dow rallied 1.5%, and the Nasdaq rose another 1.9%.

This week in an attempt to diversify the portfolio we are adding an energy play.

After a serious drought in 2023, the IPO market started picking up steam in 2024 and looks ready to heat up in 2025. Here are two upcoming IPOs to watch.

So with the Detroit auto show starting this week and running through January 25, I’ve been paying attention to what might be coming down the line. No surprise, there are lots of electric and hybrid concept cars on display, including the Chevy Volt. And yes, the Volt is still scheduled to go into production--at the end of 2010, about 23 months from now. That’s a long ways off, especially when you realize that a full two years have passed already since the car was first announced.